Participants 404 544 8
METHODS In a prospective randomised trial, 254 patients with colon cancer were randomly assigned postoperative ASI or no adjuvant treatment.
Participants 1258 1413 3
ASI was seen in patients with stage II disease, with a significantly longer recurrence-free period (p=0.011) and 61% (18-81) risk reduction for recurrences
Participants 1668 1704 3
patients with stage II colon cancer.
